Engineering Psychoplastogens: Toward a Safer Alternative for Treating Depression
Identification of psychoplastogenic isoDMT analogs is a concrete step forward in using psychedelics for treating patients who suffer from depression.
Depression
What is the Mystical Experience Questionnaire?
The MEQ is a self-report measure that provides insight into a key aspect of the psychedelic experience.
Equity and Accessibility of MDMA-Assisted Therapy
Psychedelic medicine continues to move forward, but minority communities are being left behind.
Methoxetamine: Cousin of Ketamine
The characterization of methoxetamine, a ketamine analog, and how its action on the serotonin system sets it apart.
The Top 10 Psychedelic Research Papers of 2020
Psychedelic-assisted psychotherapy leads the way in 2020’s top psychedelic papers.
How to Change Your Ability to Change
The monoamine hypothesis of depression leaves many patients without effective help. It’s time for a paradigm shift, and psychedelics may be leading the way.
Pilot Study of Psilocybin-Assisted Group Therapy in Older AIDS Survivors
Feasibility, safety, and potential efficacy of psilocybin-assisted group therapy was demonstrated in treating demoralization in this marginalized population.
Ketamine Helps People Dislike Themselves Less
New research shows that ketamine reduces self-dislike, loosening the rigid prejudice toward oneself that can constitute depression.
Examining the Effects of Psychedelics on Experiential Avoidance
Experiential avoidance is one transdiagnostic process that may be implicated in the therapeutic benefits of psychedelics.
Ketamine-Induced Brain Rhythm Causes Dissociation: From Mice to Man
While ketamine produces a whole symphony of effects in the brain, surprisingly, a localized neural oscillation in a lesser-known area of the brain is enough to cause feelings of dissociation.